The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I have no doubts that this is going to be a very popular product, whether one suffers from diagnosed ED, or not.
Apart from the ED market, There are numerous occasions whereby perfectly young & healthy men have erection issues, stress, overtired, ‘stage fright’ with a new partner, too much alcohol etc etc.
Having some gel handy, aswell as a condom or 2, will become the norm.
In regards to the reviews, The NHS has approved the product for prescription, so it has already undergone strict approval processes proving its effectiveness.
My interest at this stage is how much FUM is going to be worth within 6, 12, 18 months time?
If annual sales accelerate and Eroxon takes a minimum of 20% of the Global market (£4.7Bn) then consider our MCap then.
Personally, being able to buy OTC & use a product like Eroxon, that works within 10 minutes, without side effects, will Trump products that take an hour, such as Viagra, with a number of well documented side effects, plus an interview before one can purchase it.
So, I consider our market will gain increasing traction and eventual sales will be phenomenal.
The sticky SP is down to the Bots exercising their control atm, I suspect some clever clogs is accumulating a shed load, and whilst that’s underway, the AT algobots put the brakes on any potential upward movement.
We’ll see how long it lasts , but meanwhile, in the background, rollout continues, sales build, and at some point this will start flying.
Well, over 1M traded ( all buys) so perhaps something is afoot.
I kind of think 5.5p was achieved on licence reinstatement so still sitting at 2.9p (with existing investors investing further considerable amounts at 4p) is bargain territory.
Anyway, let’s see how today pans out.
Morning Paul, yes, I’ve noticed that sudden stock activity has increased prior to news in the past, And I would suggest news is probably due fairly soon, it’s been quiet for several months.
I’m tempted to add but will hold off for now, I’m maintaining a reasonable holding and like all things, patience is required.
However, a few more buys and this will suddenly move, which invariably attracts the attention of those regular names, which were now familiar with.